Isabella C. Glitza, MD, discusses a single-center phase I/Ib trial of concurrent intravenous and intrathecal nivolumab for patients with metastatic melanoma and leptomeningeal disease.
Isabella C. Glitza, MD
Advertisement
Articles by Isabella C. Glitza, MD
Advertisement
Latest Updated Articles
Dr. Glitza on Intrathecal Nivolumab Approaches in Leptomeningeal DiseaseNovember 23rd 2019
Advertisement
Advertisement
Trending on OncLive
1
KEYNOTE-D46 Trial Is Discontinued With Sacituzumab Govitecan Plus Pembrolizumab in PD-L1–High NSCLC
2
FDA Flashback: Breast Cancer Decisions and News From May 2026
3
ASCO 2026 Ushers In a New Era for Pancreatic Cancer, Expands Targeted Therapy Options Across the GI Spectrum
4
May’s GI Monthly Rewind: A Landmark Approval in CCA, Expanded Access for Daraxonrasib, and More Key Pipeline Updates
5